Mark R. Ziebell
2021
Compensation breakdown
| Bonus | $38,117 |
|---|---|
| Non-Equity Incentive Plan | $225,460 |
| Option Awards | $245,017 |
| Salary | $395,503 |
| Stock Awards | $105,015 |
| Other | $48,667 |
| Total | $1,057,779 |
Ziebell received $395.5K in salary, accounting for 37% of the total pay in 2021.
Ziebell also received $38.1K in bonus, $225.5K in non-equity incentive plan, $245K in option awards, $105K in stock awards and $48.7K in other compensation.
Rankings
In 2021, Mark R. Ziebell's compensation ranked 8,613th out of 12,415 executives tracked by ExecPay. In other words, Ziebell earned more than 30.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,613 out of 12,415 | 31st |
Division Manufacturing | 3,818 out of 5,505 | 31st |
Major group Chemicals And Allied Products | 1,690 out of 2,375 | 29th |
Industry group Drugs | 1,504 out of 2,096 | 28th |
Industry Pharmaceutical Preparations | 1,121 out of 1,546 | 28th |
Pay ratio
| Mark R. Ziebell's Pay | $1,057,779 |
|---|---|
| Median Employee's Pay | $104,222 |
| Pay Ratio | 10to 1 |
In 2021, the annual total compensation of Mark R. Ziebell was $1,057,779.
The annual total compensation of the median employee at Peregrine Pharmaceuticals was $104,222.
The ratio of Mark R. Ziebell's pay to the pay of median employee was therefore 10 to one.
Ziebell's colleagues
We found three more compensation records of executives who worked with Mark R. Ziebell at Peregrine Pharmaceuticals in 2021.
News
August 28, 2023
August 29, 2022
August 27, 2021
August 27, 2020
August 21, 2019
August 17, 2018